Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Contact™ Therapy™ Cool Path™ Cardiac Ablation System in Conjunction With EnSite Velocity Contact™ Technology for the Treatment of Typical Atrial Flutter

NCT01401361 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01401361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01401361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Contact™ Therapy™ Cool Path™ Cardiac Ablation System in Conjunction With EnSite Velocity Contact™ Technology for the Treatment of Typical Atrial Flutter
Lead sponsor
Abbott Medical Devices
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2011
Completion date
September 30, 2012
Enrollment
150 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

typical atrial flutter